# Multi-Omics AI/ML & Cancer Genomics Pipeline

An enterprise-grade, end-to-end computational framework designed to integrate high-dimensional multi-omics datasets, perform robust feature engineering, and isolate actionable molecular targets for stratified clinical trial design and drug discovery.

## Primary Dataset
Built and validated using multi-omics clinical and molecular profiling data sourced from **TCGA (The Cancer Genome Atlas)** via **cBioPortal** (specifically targeting breast cancer cohorts).


## 🚀 Industrial Utility & Translation Link
This repository delivers production-ready computational assets engineered to interface with the R&D pipelines of elite South Korean biotechnology and pharmaceutical firms partnered with POSTECH and KAIST (such as Samsung Biologics, Geninus, or SK Bioscience).
* **De-risking Drug Discovery:** Accelerating target identification through pre-validated, independent co-expression modules (e.g., GLI3/BBOF1), mitigating multi-million-dollar wet-lab failure rates.
* **Optimizing Clinical Trials:** Providing algorithmic classification and deep survival models to stratify patient cohorts, minimizing trial dropout rates by identifying non-responders early.

---

## 📂 Repository Architecture & Module Development Status

### 🔹 Module 01: Multi-Omics Data Ingestion & Structuring
* **Status:** Complete ✅
* **Core Focus:** Establishing robust data ingestion pipelines for multi-dimensional clinical and molecular profiling cohorts.
* **Key Features:** 
  * Automated loading and harmonization of multi-omics matrices (transcriptomics, somatic mutations, and clinical attributes) sourced from **TCGA via cBioPortal**.
  * Memory-optimized data structures using `NumPy`/`Pandas` for high-throughput matrix manipulations.
  * Clinical data parsing, missing-value handling, and sample ID synchronization across diverse omics layers.

 
### 🔹 Module 02: Advanced Feature Engineering
* **Status:** Complete ✅
* **Core Focus:** Transforming raw, noisy molecular vectors into high-signal inputs optimized for non-linear machine learning architectures.
* **Key Features:** Z-score normalization, quantile normalization across divergent omics platforms, variance filtering, and categorical encoding of complex phenotypic clinical covariates.

### 🔹 Module 03: Mutational Signature Analysis (Architectural Pivot)
* **Status:** Bypassed due to tool constraints ✅
* **Core Focus:** Addressed environment-level formatting and tool dependencies by strategically pivoting away from unstable matrix generators.
* **Key Features:** 
  * Bypassed classical 96-trinucleotide extraction to avoid heavy local reference genome (GRCh37) disk dependencies in cloud environments.
  * Integrated the robust, continuous **Tumor Mutational Burden (TMB)** proxy score engineered in Module 2 as the primary high-variance quantitative mutation feature for downstream machine learning.
 

### 🔹 Module 04: Multi-Omics Data Integration
* **Status:** Complete ✅
* **Core Focus:** Horizontal and vertical integration of high-dimensional genomic, transcriptomic, and clinical tensors.
* **Key Features:** Construction of non-linear dimensional reductions including **UMAP Projections of Master Multi-Omics Tensors** to capture continuous biological trajectories, and multi-assay profile synchronization.

### 🔹 Module 05: Integrated Exploratory Data Analysis (EDA)
* **Status:** Complete ✅
* **Core Focus:** Publication-grade statistical modeling and visual evaluation of differential molecular features.
* **Key Features:** 
  * Rigorous Differential Gene Expression (DGE) analysis with low-count filtering and fold-change shrinkage algorithms (Visualized via Volcano Distributions).
  * Cross-Omics Regulatory Co-Expression Networks capturing Pearson correlation metrics ($r$) between clinical metrics (Age, Grade, Overall Survival) and oncogenic drivers (*PHF7*, *BBC3*, *GLI3*, *CDCA5*).

---

## 🔮 Upcoming Core Deployments (AI/ML & Production Roadmap)

### 🔸 Module 06: Machine Learning Classification Framework
* **Status:** In Development 🏗️ (Planned / Next Phase)
* **Core Focus:** Transitioning downstream data matrices into robust predictive classifiers for phenotypic outcomes.
* **Implementations:** Implementation of supervised learning models (Random Forests, Gradient Boosting Machines, SVMs) tuned via cross-validation to predict chemotherapy responses and categorical clinical end-points using integrated multi-omics matrices.

### 🔸 Module 07: Scalable ML Pipelines & Containerization
* **Status:** Upcoming ⏳ (Future Workflow)
* **Core Focus:** Moving exploratory code scripts into production-ready, reproducible cloud-native workflows.
* **Implementations:** End-to-end automated pipeline orchestration via **Snakemake / Nextflow**, environment encapsulation utilizing **Docker**, and localized cluster resource allocation mapping.

### 🔸 Module 08: Deep Survival & Predictive Modeling (Target Dynamics)
* **Status:** Upcoming ⏳ (Future Workflow)
* **Core Focus:** Implementing deep learning strategies to evaluate continuous molecular biomarker metrics alongside clinical variables.
* **Implementations:** Deployment of **DeepSurv (Deep Cox Proportional Hazards Networks)** for precise survival curves estimation, algorithmically profiling strategic target candidates (MD8, GLI3/BBOF1, PHF7/CDC45), and utilizing SHAP frameworks for prognostic biomarker verification.

---

## 🛠️ Technical Stack
* **Languages:** Python (3.9+)
* **Data Science & ML:** NumPy, Pandas, Scikit-Learn, SciPy, PyTorch / TensorFlow (DeepSurv)
* **Bioinformatics Ecosystem:** Biopython, Scanpy / Anndata (Tensor manipulations), gseapy, Snakemake, Docker

